4 ms·
No, that's preposterous, paying 5x more won't increase production capacity any more. There's already massive incentive to ship first, since there are competing
by epistasis 6y ago
No, that's preposterous, paying 5x more won't increase production capacity any more.
There's already massive incentive to ship first, since there are competing vaccines. If an additional $10B-$100B could result in additional production of mRNA vaccine, it would have been delivered by governments if not by investors.
This is simply a new tech with new techniques. Throwing extra money at a problem when there isn't a chance of increasing production capacity only causes inflation of prices, and rentierism. There is no benefit.
- feral 6y agoIt's a huge claim to say that $100B extra couldn't have resulted in a speed up. What makes you so sure of that? What's the manufacturing bottleneck that an extra $100B up front couldn't parallelize? I just have trouble believing that without some evidence?
- BurningFrog 6y agoFor mRNA vaccines, this is the first time they've ever been produced at all, and it's for the biggest vaccination campaign in history. So I can see how that can't go much faster. For regular tech vaccines, you're probably right.
- feral 6y agoOK, but conversely there were literally no mRNA vaccines mass produced a year ago, and now they are delivering hundreds of millions of doses this year - so they've clearly being able to scale production quite quickly. Its a big claim to say another $100B wouldn't have scaled it faster. I'm sure they still have bottlenecks, and financial risks they weren't willing to take. $100B is a lot of resources - but a justified amount given the economic costs, which is the point.
- epistasis 6y agoIf you're writing software, and want the project to be completed faster, does throwing another $100B at a project make it go faster? Usually, this will slow it down, not make it go faster. A classic of the software engineering industry, The Mythical Man Month, is all about this process. This is a similar sort of process. There's extremely specialized knowledge held by only a tiny number of people, and though there is a plan to vastly expand production, it's never been done before. The bottleneck is not money, the bottleneck is people. People who have undoubtedly been working themselves to the bone to get this done as quickly as possible.
- feral 6y ago>If you're writing software Yes, 100% yes. Adding substantial resources can hugely speed up a project. I will requisition the very best engineers, the best support staff, remove all financial bottlenecks, dedicate shadowing teams to work in isolation in parallel on the critical sections, etc. > A classic of the software engineering industry, The Mythical Man Month, is all about this process. First off, if i recall correctly, and it's probably been 20 years since I read it, that mostly applies to late projects that have already gone off the rails. The broader point isn't true anyway. We're way better at writing software than we used to be. I've personally been on quite a few software projects where they became more strategic or promising than they initially seemed, and we threw more engineers at them to speed them up, and they sped up excellently.
- fennecfoxen 6y agoThey're not writing software. Insofar as the vaccine is like software, they wrote the software in about a week. The problem is deploying the software. This is a mechanical problem. It involves setting up assembly lines. These lines consist of expensive medical equipment, highly skilled installation experts, and skilled operators. $100 billion could definitely buy or lease more equipment, get it installed, get it inspected, and pay more operators to operate the equipment. It could pay for for scientists and technicians working in related med-tech fields. It could pay their current employers to lend them from their current jobs, guaranteeing their positions upon return. The money could likewise supply any needed training, and if necessary, it could pay them extra money and extra vacation to compensate for the disruption in their lives from working third-shift, so that the machines run overnight. Money to the tune of billions and hiring lots of the best people is specifically what makes it so people don't have to "[work] themselves to the bone".
- dependsontheq 6y agoA tech comparison would be 4 or maybe 3 nm chips. Imagine everybody in the world would fork over 200B and order 7 billion chips this year... your constraint in that case is the manufacturing equipment and there are only so many experts in that area. The vaccine technologies we are using are scaled for the first time so you don’t have a big pool of experts or companies. The Chinese vaccine is probably the one best suited for scaling up and they are doing that rapidly.
- epistasis 6y agoIt's a far more remarkable claim that $100B would improve production capacity, since that's a tiny tiny fraction of the costs of delay. But if you think that producers are intentionally holding back, and don't understand mRNA vaccine differences from adenovirus vaccines that have been used forever, this might help: https://blogs.sciencemag.org/pipeline/archives/2021/02/02/myths-of-vaccine-manufacturing https://blogs.sciencemag.org/pipeline/archives/2021/02/02/my...
- fennecfoxen 6y ago> If an additional $10B-$100B could result in additional production of mRNA vaccine, it would have been delivered by governments if not by investors. No. No. No. Not only is there no guarantee that it would have been delivered by governments, there is a major counterexample affecting hundreds of millions of people: the European Union. The EU tasked a specific body, the European Commission, to negotiate vaccine purchases for the entire bloc at once. The commission approached vaccine negotiations like a trade deal, because they usually negotiate trade deals, and ended up extracting terms that would have been good for a trade deal. They refused to go easy on the manufacturers, and thus "saved" themselves many billions — billions that they would have been much better off sacrificing (to make the negotiations faster, instead of taking months) or outright spending (to speed up production). https://www.economist.com/europe/2021/02/03/how-europe-dodges-responsibility-for-its-vaccine-fiasco https://www.economist.com/europe/2021/02/03/how-europe-dodge... https://www.wsj.com/articles/how-europe-tripped-in-covid-19-vaccine-race-11612293218 https://www.wsj.com/articles/how-europe-tripped-in-covid-19-... https://www.politico.eu/article/europe-coronavirus-vaccine-struggle-pfizer-biontech-astrazeneca/ https://www.politico.eu/article/europe-coronavirus-vaccine-s... Now they are tripping over themselves in an attempt to salvage the mess they made, issuing ill-considered threats to seize production that has been pledged abroad, rather than trying to speed things up. https://www.economist.com/graphic-detail/2021/02/01/vaccine-protectionism-endangers-the-global-fight-against-covid-19 https://www.economist.com/graphic-detail/2021/02/01/vaccine-...
- Ulrich2 6y agoPlease note that the EU is the _only_ Western country that is currently exporting vaccines to the world. It is the US + UK that are blocking all exports. Even Canada gets its vaccines from the EU, since the US is not sending them any. So yes, clearly the EU has made mistakes (fully agree with the 1st part of your post), but they had good intentions and it is not as bad as you make it sound.
- brigandish 6y ago> It is the US + UK that are blocking all exports No. The UK government publishes a list of medicines blocked for export[1] and the vaccine isn’t on the list. The EU is solely to blame for being at the back of the queue and are the only state I know of to threaten blocking exports. [1] https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/933527/medicines_that_cannot_be_parallel_exported_from_the_UK.csv/preview https://assets.publishing.service.gov.uk/government/uploads/...